Pubblicazioni

Detection of 5Î±-reductase inhibitors by UPLCâMS/MS: Application to the definition of the excretion profile of dutasteride in urine

2019 - DRUG TESTING AND ANALYSIS

Mazzarino, M.; Martellone, L.; Comunita, F.; de la Torre, X.; Molaioni, F.; Botre, F.

Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different. Is combination therapy better than monotherapy

2015 - BMC UROLOGY

Cindolo, Luca; Pirozzi, Luisella; Sountoulides, Petros; Fanizza, Caterina; Romero, Marilena; Castellan, Pietro; Antonelli, Alessandro; Simeone, Claudio; Tubaro, Andrea; De Nunzio, Cosimo; Schips, Luigi

Pubblicazioni

Detection of 5Î±-reductase inhibitors by UPLCâMS/MS: Application to the definition of the excretion profile of dutasteride in urine

Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different. Is combination therapy better than monotherapy

Detection of 5Î±-reductase inhibitors by UPLCâMS/MS: Application to the definition of the excretion profile of dutasteride in urine